Cargando…

Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)

BACKGROUND: Methylphenidate is the most commonly used stimulant drug for the treatment of attention-deficit/hyperactivity disorder (ADHD). Research has found that methylphenidate is a “reinforcer” and that individuals with ADHD also abuse this medication. Nevertheless, the molecular consequences of...

Descripción completa

Detalles Bibliográficos
Autores principales: dela Peña, Ike, Kim, Hee Jin, Sohn, Aeree, Kim, Bung-Nyun, Han, Doug Hyun, Ryu, Jong Hoon, Shin, Chan Young, Noh, Minsoo, Cheong, Jae Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077266/
https://www.ncbi.nlm.nih.gov/pubmed/24884696
http://dx.doi.org/10.1186/1744-9081-10-17
_version_ 1782323580235677696
author dela Peña, Ike
Kim, Hee Jin
Sohn, Aeree
Kim, Bung-Nyun
Han, Doug Hyun
Ryu, Jong Hoon
Shin, Chan Young
Noh, Minsoo
Cheong, Jae Hoon
author_facet dela Peña, Ike
Kim, Hee Jin
Sohn, Aeree
Kim, Bung-Nyun
Han, Doug Hyun
Ryu, Jong Hoon
Shin, Chan Young
Noh, Minsoo
Cheong, Jae Hoon
author_sort dela Peña, Ike
collection PubMed
description BACKGROUND: Methylphenidate is the most commonly used stimulant drug for the treatment of attention-deficit/hyperactivity disorder (ADHD). Research has found that methylphenidate is a “reinforcer” and that individuals with ADHD also abuse this medication. Nevertheless, the molecular consequences of long-term recreational methylphenidate use or abuse in individuals with ADHD are not yet fully known. METHODS: Spontaneously hypertensive rats (SHR), the most validated and widely used ADHD animal model, were pretreated with methylphenidate (5 mg/kg, i.p.) during their adolescence (post-natal day [PND] 42–48) and tested for subsequent methylphenidate-induced conditioned place preference (CPP) and self-administration. Thereafter, the differentially expressed genes in the prefrontal cortex (PFC) and striatum of representative methylphenidate-treated SHRs, which showed CPP to and self-administration of methylphenidate, were analyzed. RESULTS: Genome-wide transcriptome profiling analyses revealed 30 differentially expressed genes in the PFC, which include transcripts involved in apoptosis (e.g. S100a9, Angptl4, Nfkbia), transcription (Cebpb, Per3), and neuronal plasticity (Homer1, Jam2, Asap1). In contrast, 306 genes were differentially expressed in the striatum and among them, 252 were downregulated. The main functional categories overrepresented among the downregulated genes include those involved in cell adhesion (e.g. Pcdh10, Ctbbd1, Itgb6), positive regulation of apoptosis (Perp, Taf1, Api5), (Notch3, Nsbp1, Sik1), mitochondrion organization (Prps18c, Letm1, Uqcrc2), and ubiquitin-mediated proteolysis (Nedd4, Usp27x, Ube2d2). CONCLUSION: Together, these changes indicate methylphenidate-induced neurotoxicity, altered synaptic and neuronal plasticity, energy metabolism and ubiquitin-dependent protein degradation in the brains of methylphenidate-treated SHRs, which showed methylphenidate CPP and self-administration. In addition, these findings may also reflect cognitive impairment associated with chronic methylphenidate use as demonstrated in preclinical studies. Future studies are warranted to determine the clinical significance of the present findings with regard to long-term recreational methylphenidate use or abuse in individuals with ADHD.
format Online
Article
Text
id pubmed-4077266
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40772662014-07-02 Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD) dela Peña, Ike Kim, Hee Jin Sohn, Aeree Kim, Bung-Nyun Han, Doug Hyun Ryu, Jong Hoon Shin, Chan Young Noh, Minsoo Cheong, Jae Hoon Behav Brain Funct Research BACKGROUND: Methylphenidate is the most commonly used stimulant drug for the treatment of attention-deficit/hyperactivity disorder (ADHD). Research has found that methylphenidate is a “reinforcer” and that individuals with ADHD also abuse this medication. Nevertheless, the molecular consequences of long-term recreational methylphenidate use or abuse in individuals with ADHD are not yet fully known. METHODS: Spontaneously hypertensive rats (SHR), the most validated and widely used ADHD animal model, were pretreated with methylphenidate (5 mg/kg, i.p.) during their adolescence (post-natal day [PND] 42–48) and tested for subsequent methylphenidate-induced conditioned place preference (CPP) and self-administration. Thereafter, the differentially expressed genes in the prefrontal cortex (PFC) and striatum of representative methylphenidate-treated SHRs, which showed CPP to and self-administration of methylphenidate, were analyzed. RESULTS: Genome-wide transcriptome profiling analyses revealed 30 differentially expressed genes in the PFC, which include transcripts involved in apoptosis (e.g. S100a9, Angptl4, Nfkbia), transcription (Cebpb, Per3), and neuronal plasticity (Homer1, Jam2, Asap1). In contrast, 306 genes were differentially expressed in the striatum and among them, 252 were downregulated. The main functional categories overrepresented among the downregulated genes include those involved in cell adhesion (e.g. Pcdh10, Ctbbd1, Itgb6), positive regulation of apoptosis (Perp, Taf1, Api5), (Notch3, Nsbp1, Sik1), mitochondrion organization (Prps18c, Letm1, Uqcrc2), and ubiquitin-mediated proteolysis (Nedd4, Usp27x, Ube2d2). CONCLUSION: Together, these changes indicate methylphenidate-induced neurotoxicity, altered synaptic and neuronal plasticity, energy metabolism and ubiquitin-dependent protein degradation in the brains of methylphenidate-treated SHRs, which showed methylphenidate CPP and self-administration. In addition, these findings may also reflect cognitive impairment associated with chronic methylphenidate use as demonstrated in preclinical studies. Future studies are warranted to determine the clinical significance of the present findings with regard to long-term recreational methylphenidate use or abuse in individuals with ADHD. BioMed Central 2014-05-06 /pmc/articles/PMC4077266/ /pubmed/24884696 http://dx.doi.org/10.1186/1744-9081-10-17 Text en Copyright © 2014 dela Peña et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
dela Peña, Ike
Kim, Hee Jin
Sohn, Aeree
Kim, Bung-Nyun
Han, Doug Hyun
Ryu, Jong Hoon
Shin, Chan Young
Noh, Minsoo
Cheong, Jae Hoon
Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)
title Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)
title_full Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)
title_fullStr Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)
title_full_unstemmed Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)
title_short Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD)
title_sort prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (adhd)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077266/
https://www.ncbi.nlm.nih.gov/pubmed/24884696
http://dx.doi.org/10.1186/1744-9081-10-17
work_keys_str_mv AT delapenaike prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT kimheejin prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT sohnaeree prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT kimbungnyun prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT handoughyun prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT ryujonghoon prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT shinchanyoung prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT nohminsoo prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd
AT cheongjaehoon prefrontalcorticalandstriataltranscriptionalresponsestothereinforcingeffectofrepeatedmethylphenidatetreatmentinthespontaneouslyhypertensiveratanimalmodelofattentiondeficithyperactivitydisorderadhd